Pacific Biosciences of California Inc
(NAS:PACB)
$
1.86
-0.07 (-3.63%)
Market Cap: 568.03 Mil
Enterprise Value: 1.02 Bil
PE Ratio: 0
PB Ratio: 1.17
GF Score: 55/100 Pacific Biosciences of California Inc at Bank of America Healthcare Conference Transcript
May 12, 2022 / 06:20PM GMT
Release Date Price:
$4.99
(+6.97%)
Michael Leonidovich Ryskin
BofA Securities, Research Division - Director in Equity Research & Research Analyst
We'll kick off our next session. My name is Mike Ryskin, I'm on the life science tools and diagnostics team here at Bank of America, working with Derik De Bruin. And joining us for our next fireside chat is Christian Henry, President and CEO of PacBio. Christian, thanks for taking the time in being here.
Christian O. Henry
Pacific Biosciences of California, Inc. - President, CEO & Director
Thank you. It's fun to be here in person. It's our first in-person conference, and it's been great. So, it's good to see everyone. Thank you for the time.
Questions & Answers
Michael Leonidovich Ryskin
BofA Securities, Research Division - Director in Equity Research & Research Analyst
Absolutely, absolutely. So the format is going to be a fireside chat. If anyone's got any questions, feel free to throw up your hand and we'll call on and get you involved. But just to get the ball rolling, recently
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot